BioSpace News Archive

Axonics, Inc. reported financial results for the three months ended March 31, 2023.

Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced its first quarter 2023 financial results will be released after market close on Monday, May 8, 2023.

Gilead Sciences, Inc. announced that its executives will be speaking at the following investor conferences.

Baxter International Inc., a global medtech leader, announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock.

Abcam plc, a global leader in the supply of life science research tools, notes the Form 13D filed by founder and former director Dr Jonathan Milner and related press reports.

Blood Advances, part of leading hematology journal Blood, also a Journal of the American Society of Hematology, recently published the clinical study result of BTK (Bruton Tyrosine Kinase) inhibitor orelabrutinib in Relapsed or Refractory (r/r) Mantle Cell Lymphoma (MCL) patients.

OpGen, Inc. today announced the pricing of a public offering of an aggregate of 4,495,825 shares of its common stock (or pre-funded warrants in lieu thereof) and common stock purchase warrants to purchase up to 4,495,825 shares of common stock at a combined public offering price of $0.7785 per share (or pre-funded warrant in lieu thereof) and accompanying warrant.

Curasight A/S announced that it has entered into an exclusive global license and collaboration agreement with Curium Inc. – a global leader in radiopharmaceuticals – for the development and commercialization of uTRACE® for use in prostate cancer.

Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”) today announced that it will host a live conference call and audio webcast on Monday, May 8, 2023, at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2023, and to provide a business update.

Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for RAS-addicted cancers, today announced that it will report financial results for the first quarter 2023 on Monday, May 8, 2023, after market close.